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Abstract
Thiamine triphosphate (ThTP) is found at low concentrations in most animal tissues and it may act as a phosphate donor for the
phosphorylation of proteins, suggesting a potential role in cell signaling. Two mechanisms have been proposed for the enzymatic synthesis of
ThTP. A thiamine diphosphate (ThDP) kinase (ThDP+ATPZThTP+ADP) has been purified from brewer’s yeast and shown to exist in rat
liver. However, other data suggest that, at least in skeletal muscle, adenylate kinase 1 (AK1) is responsible for ThTP synthesis. In this study,
we show that AK1 knockout mice have normal ThTP levels in skeletal muscle, heart, brain, liver and kidney, demonstrating that AK1 is not
responsible for ThTP synthesis in those tissues. We predict that the high ThTP content of particular tissues like the Electrophorus electricus
electric organ, or pig and chicken skeletal muscle is more tightly correlated with high ThDP kinase activity or low soluble ThTPase activity
than with non-stringent substrate specificity and high activity of adenylate kinase.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Thiamine triphosphate (ThTP) occurs in most animal
tissues [7] and recent data suggest that it may act as a
phosphate donor for the phosphorylation of proteins. For
instance, in Torpedo electric organ, ThTP is specifically
used for the phosphorylation of histidyl residues of rapsyn
[20], a protein required for the clustering of nicotinic
receptors at the neuromuscular junction [12]. ThTP is also
the donor for phosphorylation of as yet unidentified proteins
in rodent brain [20]. In isolated patches of neuroblastoma
cells, ThTP activates a high conductance chloride channel
possibly by phosphorylation [2]. Thus, protein phosphory-
lation by ThTP could be part of a new phosphorylation
signal conduction pathway.
Although ThTP generally accounts for less than 1% of
total thiamine, a few tissues such as pig skeletal muscle
[11], electric organ of Electrophorus electricus [4] and
chicken white muscle [18] contain even more ThTP than
the cofactor thiamine diphosphate (ThDP). Shikata et al.
[27] have suggested that this high ThTP content is
correlated with the high content of adenylate kinase
(AK; EC 2.7.4.3) in skeletal muscle and electric organ.
Indeed, these authors have shown that, in vitro, the
adenylate kinase isoform 1 (AK1) may synthesize ThTP
according to the reaction
ThDPþ ADPZThTPþ AMP ð1Þ
The same group suggested that this enzyme was also
responsible for ThTP synthesis in chicken white muscle in
vivo [18,28]. However, the significance of this reaction in
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vivo can be questioned as the conversion of ThDP to
ThTP catalyzed by AK1 in vitro has a sharp pH profile
with an optimum at 10 [26]. Moreover, physiological
concentrations of free ThDP in the cytosol are less than
10 AM [8], much lower than the Km for ThDP reported for
AK1 (830 AM).
In nerve cells and hepatocytes, the main mechanism for
ThTP synthesis, as originally proposed by Eckert and
Mo¨bus in 1964 [10] is thought to be:
ThDPþ ATPZThTPþ ADP ð2Þ
This reaction is presumably catalyzed by a ThDP
kinase (ThDP:ATP phosphoryltransferase; EC 2.7.4.15)
but, until now, the enzyme remains poorly characterized.
A purification procedure from baker’s yeast has been
described [9], but the enzyme’s specific activity was very
low. A similar ThDP kinase was also partially purified
from rat liver [29].
Nishino et al. [21] reported the purification of a ThDP
kinase from beef bovine brain but, in this case, the
substrate was protein-bound ThDP rather than free ThDP.
In any event, the specific enzymatic activity of this enzyme
preparation was so low that its biological relevance is
doubtful. Concerning the in vivo synthesis of ThTP,
previous results suggest that it is fairly rapid in the
mammalian brain. Using crude rat brain synaptoneuro-
somes [6], we observed a synthesis of ThTP occurring in
a few minutes in the presence of ThDP and ATP. Yet,
ThTP did not accumulate, presumably because of rapid
hydrolysis by a specific thiamine triphosphatase (ThTPase,
EC 3.6.1.28) present in the brain [16]. Using cultured
neuroblastoma cells, we also observed that incubation in
the presence of 14C-thiamine resulted in rapid incorpora-
tion of radioactivity into cellular ThTP [1]. Likewise, when
labeled thiamine was injected to rats intraperitonelly, a
relatively rapid incorporation into brain ThTP was
observed [8]. These results suggest that intact brain cells
can rapidly synthesize ThTP but, for unknown reasons, it
has not been possible so far to obtain a soluble enzyme
that catalyzes ThTP synthesis at an appreciable rate. On the
other hand, the presence of ThTPase appears to prevent
any significant net synthesis of ThTP in intact cells or
crude extracts [1,6].
Taken together, these studies suggest that the intra-
cellular concentration of ThTP is highly regulated, espe-
cially in neurons, and that a specific ThTPase plays a
critical role in this regulation. We have recently character-
ized a specific ThTPase [15,16] which is widely distributed
in mammalian tissues. For this protein, no sequence
homology with any other known protein or hypothetical
protein sequence deduced from expressed sequence tags
could be established [15].
Before starting a detailed investigation of the enzymatic
mechanism(s) of ThTP synthesis, it was important to rule
out the possibility that ThTP might simply be a by-product
of adenylate kinase activity. Here, we show that AK1
knockout and control mice have the same ThTP levels in
all tissues examined, even in those rich in AK1, such as
heart and skeletal muscle. Our results thus indicate that
AK1 is not responsible for ThTP synthesis in mice,
supporting a dedicated role for ThTP-specific metabolizing
enzymes.
2. Materials and methods
2.1. AK1-knockout and control mice
The homozygous AK1 deficient (AK  / ) mice were
generated as previously described [14]. Age and sex-
matched wild-type animals with a 50–50% C57BL/
6 129/Ola mixed inbred background (similar to that of
the knockout mice) were used as controls. Tissues, one liver
lobe, left kidney, heart, whole brain or gastrocnemius–
plantaris–soleus (GPS) muscle complex, were removed
from freshly killed animals (3 months old) and snap-frozen
in liquid nitrogen.
2.2. Determination of thiamine and its phosphate esters
Thiamine and thiamine phosphate esters were determined
as previously described [3,5]. Samples of mouse tissues were
homogenized in 5 volumes of 10% trichloroacetic acid
(TCA) in a glass–glass homogenizer and centrifuged
(5000 g; 15 min). The supernatant was extracted with
diethyl ether and thiamine derivatives were determined by
HPLC [5]. The method of Peterson [23] was used for the
determination of protein concentration.
The authenticity of endogenous ThTP was checked by
enzymatic hydrolysis. To 70 Al of tissular TCA extract, we
added 10 Al Bis–Tris–propane buffer (500 mM, pH 8.9), 10
Al MgSO4 (50 mM) and 10 Al purified bovine ThTPase
([15], specific activity 1.7 Amol s 1 mg  1). The mixture
was incubated at 37 jC for 10 min and the reaction was
stopped by addition of 20 Al TCA (72%). After extraction of
the TCA by 3 1.5 ml diethyl ether, the extract was
analyzed by HPLC [5].
2.3. Determination of adenylate activity
Tissue samples were homogenized with a teflon-glass
Potter–Elvehjem homogenizer in 10 volumes of medium
containing Hepes–Tris (20 mM, pH 7.5), 0.5 mM EDTA,
0.2 mM dithiothreitol and 0.2% NP-40. The total AK
activity of the homogenate was measured by the method
of Oliver [22] with slight modifications. The assay
medium contained 40 mM K–Hepes, pH 7.6, 80 mM
KCl, 5 mM MgO2, 1 mM Na2EDTA, 0.2 mM dithio-
threitol, 16 mM D-glucose, 2.5 mM NaADP, 0.6 mM
NADP + , 5 U/ml hexokinase and 2 U/ml glucose-6-
phosphate dehydrogenase. The reaction was initiated by
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the addition of homogenate (40–200 Ag of protein per
ml).
2.4. Determination of ThTPase activity
Tissue samples were homogenized in a teflon-glass
Potter–Elvehjem homogenizer in 10 volumes of Tris–Cl
buffer (50 mM, pH 7.5) containing 150 mM KCl and 0.2
mM EDTA. After centrifugation (15,000 g; 30 min),
ThTPase activity was measured as previously described
[15]. The reaction medium contained 70 Al Bis–Tris–
propane buffer (50 mM, pH 8.7), 10 Al MgCl2 (50 mM),
10 Al ThTP (1 mM) and 10 Al of the enzyme preparation at
the appropriate dilution. After incubation (20 min, 37 jC),
the reaction was stopped by addition of 500 Al of TCA 12%.
After extraction with 3 1.5 ml diethyl ether, the amount of
ThDP formed was estimated by HPLC [5].
2.5. Gel filtration
The chicken muscle extract was run on a Sephadex G-75
column (2.5 36 cm), equilibrated with 20 mM Tris–HCl
buffer (pH 7.5) containing 0.1 M NaCl and calibrated with
molecular weight markers (Amersham Biosciences). The
eluate (0.4 ml/min) was analyzed for the presence of
ThTPase activity in the 20–40 kDa range.
2.6. Statistical analyses
Statistical analyses were made by ANOVA followed by
the Fisher’s protected LSD test for post hoc comparisons. If
necessary, a multivariate analysis of variance (MANOVA) is
carried out beforehand.
3. Results and discussion
It was previously shown that AK1 knockout had surpris-
ingly mild effects on skeletal muscle and the heart, tissues
where the enzyme is expressed at relatively high levels.
AK1 deficiency had no overt effect on physiological per-
formance, but was associated with a clear decrease in
energetic efficiency [14]. In skeletal muscle (GPS complex),
genetic ablation of the AK1 gene resulted in an almost
complete loss of adenylate kinase activity (99.7% decrease
measured by incorporation of f phosphoryl groups at the
h-position of ADP), and no compensatory up-regulation of
other AK genes was observed. Response to genetic stress
did, however, result in a rewiring of phosphoryl transfer
reactions, with increased flux through the glycolytic and
creatine kinase pathways. In the heart of AK1 knockout
mice, AK1 activity was reduced by 94%, leading to com-
promised energetic metabolism under hypoxia [25].
Remaining activity could be attributed to the presence of
mitochondrial isoforms AK2 and AK3 in both types of
muscle.
Here we compared total AK activity in homogenates of
skeletal muscle, heart, brain, liver and kidney between
mutant and control animals. As anticipated, total AK activity
was always lower in AK1  / mice than in age-matched
wild-type controls (Fig. 1). The most dramatic difference was
observed in skeletal muscle, where the AK1 form is known to
be predominant. A very strong reduction in total AK activity
was also observed in heart and brain, but not in liver and
kidney of AK1  / mice. The large difference observed in
brain was unexpected, as it was previously reported that
another member of the adenylate kinase family, AK2, is
predominant in this tissue [24]. In liver, the drop in activity
did not exceed 30%, suggesting that the fractional contribu-
tion to total activity by mitochondrial AK2 and/or AK3, or
any other AK-isoform, is high in this organ.
The content of thiamine compounds found in different
tissues of mice is given in Table 1. Comparison between
AK1  / and wild-type mice showed no significant differ-
ences in the levels of thiamine derivatives (MANOVA),
despite the dramatic decrease in AK1 activity in muscle and
brain of knockout mice compared with the controls. The
lack of difference in ThTP content is most conspicuous for
skeletal muscle, where AK levels differ about 100-fold
between controls and mutants. The authenticity of skeletal
muscle ThTP was tested by hydrolysis with purified bovine
brain ThTPase and found to be completely normal (not
shown).
Remarkably, significant large variations were observed
for the tissue concentrations of thiamine, ThMP, ThDP and
ThTP between different tissues. Analysis by two-factor
ANOVA confirmed these differences for all four thiamine
compounds. For ThTP, the highest content was found in liver
and the lowest in heart. ThDP was most abundant in the heart
and occurred at 4-fold lower concentration in skeletal
muscle. Thiamine monophosphate (ThMP) was the major
thiamine compound in kidney and liver, but the significance
of this finding is unclear. Free thiamine always represented
Fig. 1. Comparison of adenylate kinase activity in tissues of AK1 proficient
(wild-type; AK1+/ + ) and deficient (AK1 / ) mice. The results are ex-
pressed as meanF SD for three animals. A two-factor ANOVA revealed
significant effects of genotype [ F(4, 20) = 62.12, P < 0.0001], tissue [ F(1,
20) = 170.56, P < 0.0001], and genotype tissue interaction [ F(4,
20) = 71.94, P< 0.0001]. Bonferroni post-test: **, P < 0.001; *, P< 0.01.
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less than 10% of the total thiamine content in all tissues
examined.
Our results demonstrate that AK1 proficiency or defi-
ciency has no effect on the relative concentrations of Th,
ThMP, ThDP and ThTP in any given tissue and does also
not affect the tissue distribution profile of thiamine deriva-
tives in vivo. This provides a strong argument against a role
for AK in thiamine phosphorylation reactions. Though it has
been demonstrated that AK1 will catalyze ThTP synthesis in
vitro (reaction (1)), the high Km for ThDP as well as the
alkaline pH optimum for this reaction argue against a role
under physiological conditions in vivo. In rat brain, most of
the cytosolic ThDP is bound to transketolase and its free
cytosolic concentration is only about 2–3 AM [1,8], much
too low for a Km of 830 AM.
Shikata et al. [26] reported that the rate of ThTP syn-
thesis by purified skeletal muscle AK1 was 16 nmol/mg of
protein in 1 h at physiological pH and 100 AM ADP and
ThDP. Taking into account that the intracellular free ThDP
concentration is about 2–3 AM and that the AK1 concen-
tration is approximately 3 AM, we could calculate that it
would take 28 days to reach an intracellular ThTP concen-
tration close to 20 AM in pig skeletal muscle (Table 2), and
this supposing that during this time, there is no hydrolysis.
These results are not in favour of the hypothesis that
AK1 is responsible for ThTP synthesis. Based on our
findings, it could still be argued that not the cytosolic
AK1 but one of the mitochondrial isoforms would be
responsible for ThTP synthesis. This is however not very
likely, as in those tissues where ThTP is the most abundant,
such as pig [11] and chicken skeletal muscle [18] or
Electrophorus electric organ [4], AK1 is largely predom-
inant and ThTP is essentially cytosolic. In brain, the amount
of mitochondrial AK seems far too low to explain the rapid
rate of ThTP synthesis. In liver, where mitochondrial AK is
more abundant, we cannot exclude that the latter might be
responsible for part of the ThTP synthetic capacity. How-
ever, most of the ThTP in hepatocytes was found to be
cytosolic [17].
Our observations therefore suggest that ThTP is synthe-
sized through a specific mechanism, presumably involving a
ThDP kinase according to reaction (2). The characterization
of this enzyme will be the subject of future investigations.
We previously suggested the existence of two ThDP pools
[1,8], the first essentially mitochondrial, associated with
ThDP-dependent enzymes, and the second, cytosolic, pre-
cursor of ThTP. It is therefore highly probable that quick
signaling events such as histidine phosphorylation [20] may
require brief momentaneous flux alterations through the
latter reaction, in response to as yet unknown signals.
Electrophorus electric organ, pig skeletal muscle and
chicken muscle have a ThTP content two orders of magni-
tude higher than mouse muscle (Table 2). It is clear that the
slight differences in AK content in pig, chicken and wild-
type mouse skeletal muscle (Table 2) cannot account for
Table 2
ThTP content, ThTPase and adenylate activities in various animals (n= 3)
ThTP content
(nmol/g of
wet weight)
ThTPase activity
(nmol g 1 of
tissue min 1)
Adenylate kinase
activity (Amol
mg 1 min 1)
E. electricus
electric organ
3.9F 0.5a ndb –
Pig skeletal
muscle
20F 2,
18.24F 5.83c
12.5F 0.5 1.03F 0.15
Chicken white
muscle
(pectoralis)
3.2F 0.4,
1.2F 0.15d
nde 1.6F 0.1
Mouse GPS
skeletal muscle
0.026F 0.006 302F 54 1.3F 0.2
a According to Ref. [4].
b Below the detection limit.
c According to Ref. [11].
d According to Ref. [18], assuming that 1 g of muscle contains 171 mg
of protein.
e After chromatography on a Sephadex G-75 column.
Table 1
Content of thiamine derivatives in normal (wild-type, wt) and AK1 knockout mice
Tissuea Genotype Mean (nmol/g wet weight)F SD (n= 5)
Thiamineb ThMPc ThDPd ThTPe Total
Brain wt 0.44F 0.16 2.1F 0.3 7.8F 1.7 0.009F 0.003 10.4F 1.4
AK / 0.37F 0.10 1.9F 0.1 7.6F 1.5 0.014F 0.010 9.9F 1.5
Liver wt 2.2F 0.5 17.2F 1.2 13.1F1.4 0.14F 0.07 32.6F 1.9
AK / 1.7F 0.8 17.1F 2.2 11.4F 2.3 0.14F 0.03 30.3F 3.8
GPS muscle complex wt 0.16F 0.02 0.49F 0.05 6.7F 0.7 0.026F 0.006 7.4F 0.7
AK / 0.21F 0.07 0.41F 0.05 6.7F 1.2 0.026F 0.008 7.3F 1.2
Kidney wt 2.8F 0.5 17.8F 3.3 14.5F 2.1 0.018F 0.010 35.1F 4.7
AK / 2.1F 0.4 16.3F 2.1 11.1F 2.2 0.009F 0.004 29.5F 4.2
Heart wt 0.35F 0.03 8.7F 1.0 26.6F 1.9 0.004F 0.002 35.7F 1.3
AK / 0.29F 0.05 6.0F 1.0 28.1F 6.0 0.008F 0.004 34.4F 6.3
a Overall significant effect of tissue by MANOVA (Wilks’ k= 0.001, P= 0.0001).
b Two-factor ANOVA F(4, 40) = 88.644, P< 0.001.
c Two-factor ANOVA F(4, 40) = 279, P< 0.001.
d Two-factor ANOVA F(4, 40) = 111, P< 0.001.
e Two-factor ANOVA F(4, 40) = 48,21, P < 0.001.
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such large differences in ThTP content. As pointed out
above (see Introduction), the intracellular ThTP concentra-
tions seems to be tightly regulated in most tissues and the
presence of a specific ThTPase is probably a key factor of
this regulation. We thus suspected that the very high ThTP
content of the abovementioned tissues might be linked to an
abnormally low expression of this enzyme. We therefore
determined the activity of the 25 kDa specific soluble
ThTPase in E. electric organ as well as in chicken and
mouse skeletal muscle. As shown in Table 2, the activity
was more than 20-fold lower in pig than in mouse skeletal
muscle. In non-mammalian tissues (E. electricus or
chicken), the enzyme appeared to be totally absent.
In the chicken muscle homogenate, ThTP was rapidly
hydrolyzed, but this hydrolysis was most probably due to
myosin, which has previously been shown to be able to
hydrolyze ThTP [13,19]. When the extract was chromato-
graphed on a Sephadex G-75 column, no ThTPase activity
was detected in the 20–40 kDa range, suggesting that the 25
kDa specific ThTPase is absent or has a very low activity in
chicken muscle. It is to be noted here that we did not
observe any difference in ThTPase activity between wild-
type and AK  / mice (not shown).
Although it is not excluded that the rate of ThTP syn-
thesis may also differ from tissue to tissue, our data suggests
an inverse correlation between the ThTP content of a tissue
and soluble ThTPase activity. Together with the fact that this
enzyme has a virtually absolute substrate specificity for
ThTP and a high catalytic efficiency (kcat/Km= 6 106 s 1
M  1) [15], these observations strongly support a determin-
ing role for ThTPase in the regulation of intracellular ThTP
levels. In mouse tissues (Table 1), and in many other
mammalian tissues [7], mean ThTP levels are very low,
suggesting that protein phosphorylation by ThTP is trig-
gered by an increase in ThTP concentration, only under
certain conditions and perhaps in particular cell populations.
As ThTP is continuously newly synthesized [1,8], there may
be an important role for (transient) down-regulation of
ThTPase activity in this specific process.
In conclusion, our results indicate that AK1 is not
involved in ThTP synthesis in vivo. The cytosolic ThTP
concentration in various tissues may therefore be predom-
inantly regulated by the soluble 25 kDa ThTPase.
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